A Best Practices Guide to Achieving Successful GRAS Status

Conducting GRAS (Generally Recognized as Safe) studies is a critical step in ensuring the safety and regulatory compliance of food ingredients and additives. This process not only assures the FDA and the public of the safety of an ingredient but also opens pathways for its commercial use in the food and beverage industry. However, the journey to achieve GRAS status can be complex, involving rigorous scientific evaluations, regulatory requirements, and adherence to safety protocols. To help food and ingredient manufacturers navigate this important process, here are best practices, supported by key facts and figures, for successfully conducting GRAS studies.

1. Define the Scope and Objectives

It is essential to clearly define the scope and objectives of GRAS studies, which includes identifying the specific ingredient, its intended use, and the target population. According to the FDA, an ingredient must meet a high threshold of safety when consumed as intended by the general public or a specific subpopulation (such as children or pregnant women). Defining these parameters ensures the study focuses on demonstrating safety within a scientifically appropriate context. 

2. Choose the Right Study Design

The selection of the appropriate study design is crucial. Depending on the ingredient, different approaches, such as toxicology studies, metabolism research, or human clinical trials, may be necessary. Toxicology studies, for example, often include LD50 tests (the dose that kills 50% of test animals), which help determine safe exposure levels. Proper study design ensures that the safety of the ingredient is supported by valid scientific data. 

3. Ensure Good Laboratory Practice (GLP) Compliance

GRAS studies must comply with Good Laboratory Practice (GLP) standards, which are crucial for ensuring data quality and integrity. Non-compliance with GLP regulations can lead to rejected studies and significant delays in achieving GRAS status. GLP compliance ensures that all processes, documentation, and research activities are consistently accurate, traceable, and replicable, which is a requirement for submission to the FDA. 

4. Use Experienced Researchers and Facilities

Partnering with experienced researchers and facilities cannot be overstated. Laboratories accredited by regulatory bodies like the American Association for Laboratory Accreditation (A2LA) or those with ISO/IEC 17025 certifications are often better equipped to conduct thorough and accurate studies. Data from industry research reveals that companies with seasoned experts are 60% more likely to succeed in their GRAS applications on the first submission compared to those who do not seek expert guidance.

5. Follow FDA Guidelines

Adhering to FDA guidelines is essential throughout the process of conducting GRAS studies. The FDA has outlined specific guidance on protocols such as the use of appropriate controls, determining sample sizes, and utilizing statistical analyses. According to a study published by the Regulatory Toxicology and Pharmacology journal, companies that fail to meet FDA standards in these areas may face rejections or requests for additional data, leading to prolonged timelines.

6. Document Everything

Comprehensive documentation is non-negotiable. From protocols and study designs to the raw data and final conclusions, thorough documentation supports the transparency and replicability of the studies. The FDA requires that all data submitted as part of a GRAS determination be detailed and retrievable for public inspection. Failing to maintain proper records can lead to non-approval or revocation of GRAS status if the data cannot be verified.

7. Consider Consultation with FDA

An often overlooked but valuable strategy is to consult with the FDA early in the process. A pre-submission consultation allows for valuable insights into what the agency expects and can help identify potential gaps in the studies before they become problematic. Data shows that companies engaging in FDA consultations prior to submission have a higher chance of receiving favorable outcomes and shortened review times. 

8. Plan for Transparency and Public Disclosure

Public disclosure is an integral part of the GRAS process. The FDA requires that companies make their safety data publicly available, and this transparency can impact the public’s perception of an ingredient’s safety. Properly preparing for this step ensures that the data presented is thorough and easily accessible to the public, preventing any future disputes or mistrust. 

9. Stay Up-to-Date with Regulatory Changes

Regulatory requirements are subject to change, and keeping abreast of these developments is essential. Between 2010 and 2020, the FDA made several updates to GRAS guidance, particularly around the criteria for scientific evidence and the process for voluntary GRAS notification. Staying informed ensures that companies are prepared to adjust their methodologies to remain compliant with the latest standards.

10. Seek Expert Advice

Ultimately, expert advice can be the determining factor in a successful GRAS application. A study conducted by the International Journal of Food Science & Technology found that companies working with external experts and consultants had a 35% faster approval process compared to those that attempted to navigate the process internally. These experts help ensure that the studies meet regulatory expectations and are prepared for submission without costly errors or delays. 

Quality Smart Solutions—Your Partner for Achieving GRAS Status 

Successfully achieving GRAS status without risk of rejection or significant delays requires a methodical approach, scientific expertise, and a thorough understanding of regulatory requirements. Quality Smart Solutions has a proven track record of guiding businesses through this intricate process. Our team of seasoned experts has partnered with numerous clients to deliver precise, compliant, and efficient GRAS submissions as well as keeping them up-to-date on the latest GRAS developments. Whether it’s assisting with study design, ensuring FDA guideline adherence, or providing consultations, Quality Smart Solutions ensures that your GRAS determination is successful. We are simply the strategic partner you need to bring your ingredients to market safely and confidently. 

Picture of Andrew Parshad

Andrew Parshad

Andrew Parshad is President, CEO and founder of Quality Smart Solutions, a North American compliance solutions provider offering regulatory and quality assurance services to comply with FDA & Health Canada brands and ingredients regulations in the categories of dietary supplements, foods, cosmetics, OTC drugs and medical devices. Andrew started Quality Smart Solutions in 2007. Since that time he and his firm has served thousands of clients worldwide . Andrew's affiliate company, Quality IMPORT Solutions that offers import agent services into the Canadian market as a government licensed importer for foods, dietary supplements and medical devices.

Book free consultation with regulatory experts

Please select all services that apply to you *